13F Holdings
中文EN

SLSN SOLESENCE, INC.

Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 883107 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.0%
TTM net income YoY364.7%
TTM EPS YoY1,152,921,504,606,847,232.0%
Revenue 3-yr CAGR17.5%
Net income 3-yr CAGR—

Margins

Gross margin31.7%
Operating margin6.0%
Net margin4.5%
FCF margin—
EBITDA margin8.0%

Returns

ROE18.2%
ROA5.8%
ROIC (approx.)25.8%
Asset turnover1.29x

Leverage & solvency

Liabilities / assets62.3%
Debt / equity0.00x
Current ratio1.73x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.72x
Accruals ratio-15.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$20.16M$15.33M$12.96M$12.48M$14.60M$20.36M$14.62M$12.57M
Cost of revenue$12.23M$10.68M$9.79M$8.94M$11.12M$13.83M$11.09M$11.19M
Gross profit$7.93M$4.65M$3.17M$3.54M$3.47M$6.53M$3.53M$1.38M
R&D expense$1.08M$947,000$1.04M$1.03M$1.08M$955,000$1.02M$1.09M
SG&A expense$2.81M$3.68M$2.80M$2.21M$3.07M$3.01M$2.11M$1.90M
Operating income$4.04M$23,000-$674,000$296,000-$677,000$2.56M$407,000-$1.61M
Interest expense——————$176,000$108,000
Pretax income$3.89M-$256,000-$936,000-$44,000-$1.02M$3.71M$231,000-$1.72M
Income tax$219,000——-$317,000$0$390,000——
Net income$3.67M-$256,000-$936,000$273,000-$1.02M$3.32M$231,000-$1.94M
EBITDA$4.35M$346,000-$361,000$517,000-$452,000$2.79M$633,000-$1.38M
EPS (basic)0.050.00-0.01—-0.010.050.00—
EPS (diluted)0.050.00-0.01—-0.010.050.00—
Weighted avg. shares (diluted)71.48M70.64M70.63M—70.50M72.58M72.63M—
Balance sheet
Cash & equivalents$1.27M$1.05M$573,000$1.29M$429,000$429,000$1.82M$1.41M
Receivables$8.36M$9.35M$6.38M$6.84M$9.71M$11.05M$9.09M$4.87M
Inventory$11.59M$12.80M$13.76M$14.88M$15.13M$19.83M$21.91M$15.62M
Current assets$23.26M$25.11M$22.61M$25.14M$29.05M$38.77M$35.90M$24.70M
PP&E, net$15.01M$14.79M$14.75M$14.33M$13.94M$13.56M$13.11M$12.73M
Total assets$44.44M$46.28M$43.99M$46.42M$50.24M$59.96M$57.02M$45.35M
Current liabilities$13.45M$26.01M$12.69M$13.93M$17.86M$22.54M$32.88M$25.77M
Total liabilities$27.69M$33.28M$30.83M$32.42M$36.76M$45.61M$46.36M$35.06M
Shareholders' equity$16.75M$13.00M$13.16M$14.00M$13.48M$14.34M$10.66M$10.29M
Shares outstanding70.65M70.65M70.63M70.61M70.54M70.48M70.10M70.10M
Cash flow statement
Operating cash flow$6.72M$191,000$1.52M$1.82M-$2.51M-$654,000-$7.22M$2.19M
Capital expenditure———————$2.59M
Free cash flow———————-$404,000
Investing cash flow-$538,000-$469,000-$528,000-$450,000-$418,000-$1.41M$133,000-$2.59M
Financing cash flow-$5.96M$751,000-$1.70M-$510,000-$750,000$4.35M$7.50M-$1.11M
Depreciation & amortization$313,000$323,000$313,000$221,000$225,000$225,000$226,000$228,000
Stock-based compensation$83,000$79,000$82,000$206,000$122,000$120,000$127,000$248,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.